THE PROTECTIVE ACTION OF MELATONIN IN GASTROESOPHAGEAL REFLUX DISEASE
Abstract
Background. It is known that the degree of damage to the mucous membrane (MM) of the esophagus in gastroesophageal reflux disease (GERD) depends on the severity of the impairment of its protective properties. The role of melatonin in the protection of the MM of the gastrointestinal tract (GIT) from the damaging effects of endogenous and exogenous factors is currently being studied.Objective. To study the characteristics of melatonin daily rhythm secretion in patients with endoscopically positive GERD and to assess the relationship of its level to the degree of MM damage to the esophagus.
Materials and methods. 59 patients with reflux esophagitis (RE) were examined. The level of melatonin metabolite was determined: 24-hour urinary 6-sulfatoxymelatonin (6-SOMT) and separately in day and night urine output. The night/day index has been calculated.
Results. In patients with erosive RE, the level of 6-SOMT in 24-hour urine and in day urine output is significantly lower than in patients with non-erosive RE. In patients with non-erosive RE, the shift of melatonin synthesis peak to daytime has been noted. The correlation between the degree of damage to the esophageal MM and 6-SOMT urine level has been established.
Conclusion. The results of the study prove the esophagoprotective action of melatonin on the MM of the esophagus in patients with endoscopically positive GERD. It is its enteral synthesis that allows for the high level of melatonin in daytime in patients with RE.
References
1. Sereda NN. Gastrojezofagealnaja refljuksnaja bolezn [Gastroesophageal reflux disease]. Sibirskij medicinskij zhurnal [Siberian Medical Journal]. 2014;127(4):133-139. (Russian).
2. Tufik S, Santos-Silva R, Taddei JA, Bittencourt LR. Obstructive sleep apnea syndrome in the Sao Paulo Epidemiologic Sleep Study. Sleep Medicine. 2010;11(5):441-446. doi: 10.1016/S1389-9457(09)70043-7
3. Lindam A, Kendall BJ, Thrift AP, Macdonald GA, O’Brien S, Lagergren J, Whiteman D. Symptoms of Obstructive Sleep Apnea, Gastroesophageal Reflux and the Risk of Barrett’s Esophagus in a Population-Based Case – Control Study. PLoS One. 2015;10(6):e0129836. doi: 10.1371/journal. pone.0129836.
4. Konturek SJ, Konturek PC, Brzozowski T, Bubenik GA. Role of melatonin in upper gastrointestinal tract. Journal of Physiology and Pharmacology. 2007;58(6):23-52.
5. Bubenik G. Thirty four years since the discovery of gastrointestinal melatonin. Journal of Physiology and Pharmacology. 2008;59(2):33-51.
6. Sommansson A, Nylander O, Sjöblom M. Melatonin de-creases duodenal epithelial paracellular permeability via a nicotinic receptor-dependent pathway in rats in vivо. Journal of Pineal Research. 2013;54(3):282-291. doi: 10.1111/jpi.12013.
7. Yuan X, Li B, Li H, Xiu R. Melatonin inhibits il-1β-induced monolayer permeability of human umbilical vein endothelial cells via Rac activation. Journal of Pineal Research. 2011;51(2):220-225. doi: 10.1111/j.1600-079X.2011.00882.x.
8. Tkach SM. Vedenie bolnyh gastrojezofagealnoj boleznju v svete poslednego amerikanskogo konsensusa [Management of patients with gastroesophageal reflux disease in the light of the recent American consensus] Gastroenterologіja [Gastroenterology]. 2013;2(48):108-113. (Russian).
9. Glantz S. Mediko-biologicheskaja statistika [Primer of Biostatistics]. Moscow: Praktika; 1999. 459 р. (Russian).
10. Klupińska G, Wiśniewska-Jarosińska М, Harasiuk А, Chojnacki С, Stec-Michalska К, Błasiak J, Reiter RJ, Chojnacki J. Nocturnal secretion of melatonin in patients with upper digestive tract disorders. Journal of Physiology and Pharmacology. 2006;57(5):41-50.
